None listed
Conditions
Brief summary
The goal of this study is to undertake rigorous scientific evaluation of the most popular Australian high-quality smoking cessation app. Screen2Quit (formally known as My QuitBuddy) in current smokers scheduled to undergo lung cancer screening. Who is it for? You may be eligible for this study if you are aged 55 years and over, you currently smoke, and you are eligible for lung cancer screening. Study details Participants will be randomised (i.e. allocated by chance) to either receive access to the Screen2Quit app, or will be directed to a tailored smoking cessation resources webpage. Participants in the Screen2Quit group will be sent a link to download the app to their phone, through which users may enter their planned quit date, smoking history, and set goals for quitting smoking. The app sends daily reminders and provides daily updates on health benefits of quitting, money saved, can be tailored to interact with the participant at self-identified "danger times" for smoking. Each participant’s use of the app will be determined through questionnaires and by accessing app analytics. Participants who do not receive access to the app will be directed to an online resource according to their jurisdiction (e.g. Queensland participants will be directed to the Qld government smoking cessation website QuitHQ). Participants will be instructed to use the app/web page resources ad lib in conjunction with whichever standard smoking cessation therapies are recommended by their treating health team (e.g. Quitline counselling, pharmacotherapy). All participants will be followed-up for 12 months post-enrolment to assess their self-reported quit rate, biochemically verified abstinence from smoking using a urine test, quit attempts, motivation, and use of counselling/pharmacotherapy. It is hoped that this study may show that the Screen2Quit app, when used with usual care, increases quit rates compared to usual care alone in smokers undergoing lung cancer screening.
Interventions
Participants undergoing lung cancer screening will be invited to participate in a smoking cessation study via an online survey where they will be assessed for eligibility. When randomised to the intervention, a personalised link to the purpose built research version of the publicly available smoking cessation smart-phone app (My QuitBuddy renamed Screen2Quit) will be sent to the participant's own mobile phone for them to download. The app will be used ad lib in conjunction with whichever standard smoking cessation therapies are recommended by their treating health team (e.g. Quitline counselling, pharmacotherapy). My Screen2Quit usage will be determined by patient questionnaires for twelve months following randomisation and the collection of "back end" data analytics. Screen2Quit is an app personalised to help people quit smoking using educational and motivational tools. Users enter their planned quit date, smoking history, and set goals for quitting smoking. The app sends daily reminders and provides daily updates on health benefits of quitting, money saved, can be tailored to interact with the participant at self identified "danger times" for smoking.
Sponsors
Study design
Eligibility
Inclusion criteria
Adults smokers who are eligible for lung cancer screening and are able to give informed consent, own a smartphone and a computer, are capable of downloading an app and have access to the internet
Exclusion criteria
Those who do not own a smartphone and/or do not have access to the internet. Smokers who are current users of a smoking cessation smartphone app.